Hemab Therapeutics Closes Upsized Initial Public Offering on Nasdaq

Leila Ahmed North America Legal Chronicle
Tagged:

Wilmer Cutler Pickering Hale and Dorr has advised Hemab Therapeutics Holdings, Inc. Goodwin Procter has advised the underwriters. Hemab Therapeutics Holdings, Inc., a clinical-stage biotechnology company,…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here